The company’s executive team is scheduled to host the call at 5:00 p.m. U.S. EDT. Investors and analysts can access the discussion via the firm's investor relations portal, where supplementary materials will be posted shortly before the event begins. A replay of the proceedings will remain available on the same digital platform for those unable to attend the live session.
Bausch Health maintains a diverse portfolio spanning gastroenterology, neuroscience, and dermatology, alongside its controlling interest in Bausch + Lomb. This upcoming update serves as a key indicator for stakeholders tracking the company's broader efforts to integrate its healthcare operations globally.
Comments (0)
No comments yet. Be the first!